Covista Inc.
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Aug 6, 2026
Contents
Restructuring Expense
- Restructuring Expense
During the year ended June 30, 2026, Covista recorded restructuring expense primarily driven by workforce reductions and prior real estate consolidations at Covista’s home office. We continue to incur restructuring charges or reversals related to exited leased space from previous restructuring actions. During the year ended June 30, 2025, Covista recorded restructuring expense primarily driven by workforce reductions, costs to exit certain course offerings, and prior real estate consolidations at Covista’s home office. During the year ended June 30, 2024, Covista recorded restructuring expense primarily driven by prior real estate consolidations at Covista’s home office. When estimating costs of exiting lease space, estimates are made which could differ materially from actual results and may result in additional restructuring charges or reversals in future periods. Termination benefit charges represent severance pay and benefits for employees impacted by workforce reductions. Restructuring expense by segment was as follows (in thousands):
| · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · Year Ended June 30, 2026 | ||||||||
| · · Real Estateand Other · · TerminationBenefits · · Total | ||||||||
| Chamberlain | | $98 | $1,926 | $2,024 | ||||
| Walden | | | — | | 715 | | 715 | |
| Medical and Veterinary | | | 120 | | 735 | | 855 | |
| Home Office | | | 519 | | 2,216 | | 2,735 | |
| Total | | $737 | | $5,592 | | $6,329 | ||
| · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · Year Ended June 30, 2025 | ||||||||
| · · Real Estateand Other · · TerminationBenefits · · Total | ||||||||
| Chamberlain | | $974 | $938 | $1,912 | ||||
| Medical and Veterinary | | | 215 | | 239 | | 454 | |
| Home Office | | | 708 | | 240 | | 948 | |
| Total | | $1,897 | | $1,417 | | $3,314 | ||
| · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · Year Ended June 30, 2024 | ||||||||
| · · Real Estateand Other · · TerminationBenefits · · Total | ||||||||
| Walden | | $(776) | $— | $(776) | ||||
| Medical and Veterinary | | | 402 | | 40 | | 442 | |
| Home Office | | | 2,204 | | — | | 2,204 | |
| Total | | $1,830 | | $40 | | $1,870 | ||
The following table summarizes the separation and restructuring plan activity for the years ended June 30, 2025 and 2026, for which cash payments are required (in thousands):
| · · · | ||
|---|---|---|
| Liability balance as of June 30, 2024 | | $— |
| Increase in liability (termination and other charges) | | 1,418 |
| Reduction in liability (payments and adjustments) | | (1,418) |
| Liability balance as of June 30, 2025 | | — |
| Increase in liability (termination and other charges) | | 5,592 |
| Reduction in liability (payments and adjustments) | | (4,068) |
| Liability balance as of June 30, 2026 | | $1,524 |
These liability balances are recorded within accrued liabilities on the Consolidated Balance Sheets.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.